Search research articles
Contact Us
Filters
Showing results (11-20 of 64) with videos related to
Page
of 7
Sort By:
Nature
|
January 5, 1973
Tissue zinc in malignant disease
K Griffith, E B Wright, T L Dormandy
Expert Opinion on Drug Metabolism & Toxicology
|
March 29, 2014
Considerations for rare variants in drug metabolism genes and the clinical implications
Britt I Drögemöller, Galen E B Wright, Louise Warnich
Human Genomics
|
October 24, 2014
Informed consent and ethical re-use of African genomic data
Galen E B Wright, Adebowale A Adeyemo, Nicki Tiffin
Nucleic Acids Research
|
April 1, 1979
Core nucleosomes by digestion of reconstructed histone-DNA complexes
P N Bryan, E B Wright, D E Olins
HGG Advances
|
November 19, 2025
Unbiased human genomic characterization of polyglutamine disorder genes to guide biological understanding and therapeutic strategies
Kevin Lucy Namuli, Britt I Drögemöller, Galen E B Wright
Nucleic Acids Research
|
December 1, 1976
Chromatin nu bodies: isolation, subfractionation and physical characterization
A L Olins, R D Carlson, E B Wright, et al.
The Pharmacogenomics Journal
|
October 26, 2016
The global spectrum of protein-coding pharmacogenomic diversity
G E B Wright, B Carleton, M R Hayden, et al.
BMC Medical Ethics
|
May 30, 2013
Ethical and legal implications of whole genome and whole exome sequencing in African populations
Galen E B Wright, Pieter G J Koornhof, Adebowale A Adeyemo, et al.
Brain Communications
|
January 13, 2025
Genomic characterization of Huntington's disease genetic modifiers informs drug target tractability
Kevin Lucy Namuli, Alana N Slike, Mason A Hollebeke, et al.
Gastroenterology
|
July 27, 2019
Genome-Wide Association Studies of Drug-Induced Liver Injury Make Progress Beyond the HLA Region
Galen E B Wright, Britt I Drögemöller, Colin J D Ross, et al.
Page
of 7
Search research articles
Search
Showing results (11-20 of 64) with videos related to
Sort By:
Page
of 7
Nature
|
January 5, 1973
Tissue zinc in malignant disease
K Griffith, E B Wright, T L Dormandy
Expert Opinion on Drug Metabolism & Toxicology
|
March 29, 2014
Considerations for rare variants in drug metabolism genes and the clinical implications
Britt I Drögemöller, Galen E B Wright, Louise Warnich
Human Genomics
|
October 24, 2014
Informed consent and ethical re-use of African genomic data
Galen E B Wright, Adebowale A Adeyemo, Nicki Tiffin
Nucleic Acids Research
|
April 1, 1979
Core nucleosomes by digestion of reconstructed histone-DNA complexes
P N Bryan, E B Wright, D E Olins
HGG Advances
|
November 19, 2025
Unbiased human genomic characterization of polyglutamine disorder genes to guide biological understanding and therapeutic strategies
Kevin Lucy Namuli, Britt I Drögemöller, Galen E B Wright
Nucleic Acids Research
|
December 1, 1976
Chromatin nu bodies: isolation, subfractionation and physical characterization
A L Olins, R D Carlson, E B Wright, et al.
The Pharmacogenomics Journal
|
October 26, 2016
The global spectrum of protein-coding pharmacogenomic diversity
G E B Wright, B Carleton, M R Hayden, et al.
BMC Medical Ethics
|
May 30, 2013
Ethical and legal implications of whole genome and whole exome sequencing in African populations
Galen E B Wright, Pieter G J Koornhof, Adebowale A Adeyemo, et al.
Brain Communications
|
January 13, 2025
Genomic characterization of Huntington's disease genetic modifiers informs drug target tractability
Kevin Lucy Namuli, Alana N Slike, Mason A Hollebeke, et al.
Gastroenterology
|
July 27, 2019
Genome-Wide Association Studies of Drug-Induced Liver Injury Make Progress Beyond the HLA Region
Galen E B Wright, Britt I Drögemöller, Colin J D Ross, et al.
Page
of 7